NeoGenomics Inc

Healthcare · Diagnostics & Research

19.60$ +6.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

NeoGenomics Inc (NEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,352 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NEO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	355	337	344	340	344	343	349	346	455	505	533	697	711	710	732	945	959	1,046	1,494	1,896	1,906	1,870	1,830	1,792	1,756	1,740	1,709	1,695	1,678	1,681	1,640	1,643	1,641	1,638	1,601	1,394	1,375	1,360	1,347	1,352
Current Assets	93	79	85	83	86	85	88	83	194	104	116	276	292	291	215	419	422	449	943	722	710	682	651	622	603	605	585	585	587	597	574	584	590	596	574	392	382	376	374	381
Cash	29	13	11	11	12	13	15	9.4	118	9.8	13	167	179	173	86	295	233	229	612	369	341	317	306	284	266	263	276	289	306	342	332	355	362	367	346	155	164	160	146	146
Cash & Short-Term Investments	29	13	11	11	12	13	15	9.4	118	9.8	13	167	179	173	86	295	284	296	803	572	543	515	481	466	444	438	418	409	402	415	385	388	388	387	358	164	164	160	146	146
Receivables	50	56	62	62	63	60	58	61	63	77	83	90	91	94	101	89	105	108	105	106	105	112	113	111	112	120	119	128	133	131	142	147	151	151	151	154	156	159	167	175
Inventory	6.0	6.3	6.0	5.5	6.1	7.5	7.5	6.9	6.8	8.7	9.7	8.7	13	14	20	22	21	30	21	21	22	23	24	22	24	24	24	25	24	24	20	23	24	27	30	34	28	29	30	27
Property, Plant & Equipment	34	34	37	36	35	37	40	43	41	61	61	59	62	64	83	84	85	86	94	167	107	212	211	211	107	102	103	100	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	146	147	147	147	147	147	147	147	147	198	196	196	199	199	211	211	211	180	211	500	526	527	527	527	523	523	523	523	523	523	523	523	523	523	523	524	524	524	524	524
Intangible Assets	82	77	75	74	76	74	73	71	70	140	138	135	129	127	128	126	123	152	118	471	451	442	434	425	417	408	399	391	382	373	365	356	348	340	331	302	294	287	279	271
Total Liabilities	109	151	156	143	144	138	141	182	152	185	209	207	214	202	227	291	293	352	651	748	769	762	755	749	743	742	735	739	731	740	717	727	733	736	713	540	536	523	518	566
Current Liabilities	35	60	40	35	40	35	43	48	47	61	73	59	69	64	68	62	65	73	68	99	93	87	82	83	85	90	87	95	93	96	77	290	296	301	280	100	98	88	85	106
Short-Term Debt	5.6	31	8.8	8.6	8.5	9.0	16	18	21	20	18	8.4	16	8.4	14	9.0	8.4	7.8	7.2	7.6	8.6	8.0	6.6	6.1	6.5	6.7	7.0	7.4	6.2	5.6	4.5	204	204	204	204	4.1	4.5	4.8	4.8	5.4
Accounts Payable	30	29	21	16	15	10	13	12	9.2	18	17	16	18	20	20	19	18	25	19	23	29	18	20	17	14	21	23	18	17	20	18	17	17	22	16	27	23	23	26	100
Long-Term Debt	52	92	96	95	92	91	84	121	90	93	91	94	93	92	91	165	166	168	530	531	532	532	533	534	535	535	536	537	537	538	539	340	340	340	341	341	341	342	342	374
Shareholders' Equity	246	187	187	197	200	206	208	164	304	320	324	490	497	507	505	654	666	694	844	1,148	1,137	1,108	1,075	1,044	1,013	998	974	956	947	942	923	916	908	902	888	854	838	837	829	786
Retained Earnings	-38	-52	-49	-52	-60	-57	-60	-54	-52	-51	-54	-52	-18	-11	-18	-25	-23	-7.2	-29	47	27	-15	-64	-100	-136	-159	-190	-214	-233	-247	-274	-293	-310	-326	-352	-397	-424	-434	-451	-449
Shares Outstanding	78	78	16	16	16	16	16	18	18	19	19	20	22	22	21	22	22	23	23	26	25	25	25	25	25	25	25	25	25	25	25	25	25	25	25	26	26	26	26	26

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings